Randomized Phase II Study of Olaparib Maintenance Following Cabazitaxel-Carboplatin Induction Chemotherapy in Men With Aggressive Variant Prostate Cancer (AVPC)
Randomized Phase II Study of Olaparib Maintenance Following Cabazitaxel-Carboplatin Induction Chemotherapy in Men With Aggressive Variant Prostate Cancer (AVPC) Condition: Prostate Cancer Aggressiveness, Prostate Carcinoma Intervention: Drug: Cabazitaxel Drug: Carboplatin Drug: Prednisone 5Mg Drug: Olaparib Purpose: The goal of this clinical research study is to learn if olaparib, when given after treatment with cabazitaxel, carboplatin, […]